Company: LGN
Filing Date: 2025-05-14
Form Type: DRS/A
Source: 0000950123-25-005247
Chunk: 92

Company: Legence Corp.
Filing Date: 2025-05-14
Form: DRS/A
Chunk 92
---
 respect to the foregoing could have an adverse impact on the trading price of our Class A Common Stock.

Upon the listing of our shares on the Nasdaq, we will be a “controlled company” within the meaning of the rules of the Nasdaq and, as a result, will qualify for, but do not currently intend to rely on, exemptions from certain corporate governance requirements. In the event we elect to rely on these exemptions in the future, you will not have the same protections afforded to stockholders of companies that are subject to such requirements.

Upon completion of this offering, our Sponsor will control a
majority of our voting power. As a result, we will be a “controlled company” within the meaning of the Nasdaq corporate governance standards. Under the Nasdaq rules, a company of which more than 50% of the voting power is held by an
individual, group or another company is a “controlled company” and need not comply with certain requirements, including the requirement that a majority of the board of directors consist of independent directors and the requirements that
our compensation and nominating and governance committees be composed entirely of independent directors. Following this offering, we do not intend to utilize these exemptions, However, for so long as we qualify as a “controlled company,”
we will maintain the option to utilize some or all of these exemptions. If we utilize these exemptions, we may not have a majority of independent directors and our compensation and nominating and governance committees may not consist entirely of
independent directors, and such committees will not be subject to annual performance evaluations. Accordingly, in the event we elect to rely on these exemptions in the future, you may not have the same protections afforded to stockholders of
companies that are subject to all of the corporate governance requirements of the Nasdaq. See “Management—Status as a Controlled Company.”

Future sales of our Class A Common Stock or LGN Units in the public market could reduce the market price of our Class A Common Stock, and any additional capital raised by us through the sale of equity or convertible or exchangeable securities may dilute your ownership in us.

We may sell additional shares of Class A Common Stock in subsequent public offerings. We may also issue additional shares of Class A
Common Stock or convertible or exchangeable securities (including LGN Units). After the completion of this offering, we will have outstanding shares of our Class A Common Stock of which our Sponsor will own
shares of our Class A Common Stock (or shares of Class A

56

Confidential Treatment Requested